Graphite Bio Inc (GRPH) Peer Comparison

$22.26

$0.00 (0.00%)

As on 22-Mar-2024 09:30EDT

Market cap

$185 Mln

Revenue (TTM)

$10 Mln

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Edit

	Graphite Bio Inc (GRPH)	Homology Medicines (FIXX)
Market cap ($ Mln)	185	3
Revenue ($ Mln)	--	1
Net Profit ($ Mln)	-124.65	-112.96
Net Margin (%)	-957.77	-2,731.17
RoE (%)	-51.95	-90.02
Price to Earnings	--	--
Price-To-Book	1.01	0.04

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Graphite Bio Inc (GRPH)	Homology Medicines (FIXX)
Operating Revenue	0.00	1.16
Cost of Revenue	2.41	0.58
Gross Profit	-2.41	0.58
Operating Expenses	70.70	92.68
Operating Profit (EBIT)	-73.11	-92.10
Other Income	--	--
Profit before Tax	-124.65	-87.08
Provision for Tax	--	25.88
Profit after Tax (Net Income)	-124.65	-112.96
Minority Interest	--	--
Consolidated Profit	--	--

Liabilities ($ Mln)

	Graphite Bio Inc (GRPH)	Homology Medicines (FIXX)
Shareholder's Funds	183.58	72.99
Minority Interest	--	--
Non-Current Liabilities	0.08	221.55
Current Liabilities	4.80	11.57
Total Liabilities	188.46	306.12

Assets ($ Mln)

	Graphite Bio Inc (GRPH)	Homology Medicines (FIXX)
Non-Current Assets	0.44	222.21
Current Assets	188.02	83.91
Total Assets	188.46	306.12
Total Debt*	0.36	1.32
Net Current Assets	183.22	72.34

Cashflow ($ Mln)

	Graphite Bio Inc (GRPH)	Homology Medicines (FIXX)
Cash From Operating Activities	-90.01	-96.23
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	0.19	0.18
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Graphite Bio Inc (GRPH)	Homology Medicines (FIXX)
ROCE (%)	-51.29	-80.18
ROE (%)	-51.95	-90.02
ROA (%)	-48.85	-42.26
EBIT Margin (%)	--	--
Net Margin (%)	--	-9,771.71
Cash Profit Margin (%)	--	--

Growth Ratios

	Graphite Bio Inc (GRPH)	Homology Medicines (FIXX)
Revenue Growth (%)	--	-0.64
EBIT Growth (%)	--	--
Net Profit Growth (%)	-29.22	-23,487.37
EPS Growth (%)	-0.24	-232.73
Book Value Growth (%)	--	--

Valuation Ratios

	Graphite Bio Inc (GRPH)	Homology Medicines (FIXX)
Price / Earnings	-1.22	-0.31
Price / Book Value	0.83	0.48
Dividend Yield (%)	--	--
EV/EBITDA	0.47	0.50
Market Cap ($ Cr)	--	--

Solvency Ratios

	Graphite Bio Inc (GRPH)	Homology Medicines (FIXX)
Debt to Equity	0.00	0.02
Short term debt to equity ratio	0.00	0.02
Current Ratio	39.20	7.25
Quick Ratio	--	--
Interest Coverage	--	--

Operating Efficiency Ratios

	Graphite Bio Inc (GRPH)	Homology Medicines (FIXX)
Debtors to sales (%)	--	--
Asset Turnover	0.00	0.00
Receivable days	--	94.79
Inventory Days	--	--
Payable days	216.84	1,383.27
Cash Conversion Cycle	--	--

Annual
Quarterly